Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Merck KGaA

Start price
Target price
Perf. (%)
€160.50
02.04.24
-
02.04.25
-5.05%
26.04.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€23.28
01.04.25
-
08.03.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
-
01.04.25
-
08.03.24

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€9.27
01.04.25
-
08.03.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€163.60
30.03.24
€172.00
22.07.24
-6.85%
26.04.24

buy
Evotec SE

Start price
Target price
Perf. (%)
€14.68
29.03.24
€15.00
29.03.25
-36.31%
26.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Medigene AG

Start price
Target price
Perf. (%)
€2.07
28.03.24
-
28.03.25
-26.57%
26.04.24

B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€3.67
26.03.24
€20.00
11.11.24
-21.80%
26.04.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€27.13
26.03.24
€36.00
26.03.25
1.29%
26.04.24

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Biofrontera AG

Start price
Target price
Perf. (%)
€0.37
24.03.24
-
24.03.25
-7.36%
26.04.24

Formycon AG

Start price
Target price
Perf. (%)
€46.05
24.03.24
-
24.03.25
-13.68%
26.04.24

buy
Merck KGaA

Start price
Target price
Perf. (%)
€156.35
17.03.24
-
17.03.25
-2.53%
26.04.24

buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€23.60
12.03.24
-
12.03.25
-14.41%
26.04.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€26.33
09.03.24
-
09.03.25
4.37%
26.04.24

buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€0.68
06.03.24
-
06.03.25
16.32%
26.04.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
4.41%
26.04.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.63
04.03.24
€1.00
04.03.25
-12.50%
08.03.24

Could be worthwhile Investment >10% per year
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€3.07
28.02.24
-
28.02.25
-2.61%
26.04.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€29.02
22.02.24
€40.00
22.02.25
-5.31%
26.04.24

Merck KGaA

Start price
Target price
Perf. (%)
€155.45
15.02.24
€120.00
15.02.25
-1.96%
26.04.24

Evotec SE

Start price
Target price
Perf. (%)
€13.43
15.02.24
-
15.02.25
-30.38%
26.04.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€27.88
09.02.24
€50.00
09.02.25
-1.44%
26.04.24

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.25
06.02.24
€7.00
06.02.25
-7.59%
25.04.24

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€32.11
22.01.24
-
22.01.25
110.99%
26.04.24

Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€38.06
16.01.24
€45.00
16.01.25
78.01%
26.04.24